These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 25455830)

  • 21. Refining efficacy: allosterism and bias in G protein-coupled receptor signaling.
    Luttrell LM; Kenakin TP
    Methods Mol Biol; 2011; 756():3-35. PubMed ID: 21870218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential.
    Seyedabadi M; Ghahremani MH; Albert PR
    Pharmacol Ther; 2019 Aug; 200():148-178. PubMed ID: 31075355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional selectivity and dualsteric/bitopic GPCR targeting.
    Schrage R; Kostenis E
    Curr Opin Pharmacol; 2017 Feb; 32():85-90. PubMed ID: 28027487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Pluridimensional View of Biased Agonism.
    Costa-Neto CM; Parreiras-E-Silva LT; Bouvier M
    Mol Pharmacol; 2016 Nov; 90(5):587-595. PubMed ID: 27638872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling small molecule-compound binding to G-protein-coupled receptors.
    Vaidehi N; Pease JE; Horuk R
    Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data.
    Stott LA; Hall DA; Holliday ND
    Biochem Pharmacol; 2016 Feb; 101():1-12. PubMed ID: 26478533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity.
    Antony J; Kellershohn K; Mohr-Andrä M; Kebig A; Prilla S; Muth M; Heller E; Disingrini T; Dallanoce C; Bertoni S; Schrobang J; Tränkle C; Kostenis E; Christopoulos A; Höltje HD; Barocelli E; De Amici M; Holzgrabe U; Mohr K
    FASEB J; 2009 Feb; 23(2):442-50. PubMed ID: 18842964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel insights into biased agonism at G protein-coupled receptors and their potential for drug design.
    Martí-Solano M; Guixà-González R; Sanz F; Pastor M; Selent J
    Curr Pharm Des; 2013; 19(28):5156-66. PubMed ID: 23621547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How ligands and signalling proteins affect G-protein-coupled receptors' conformational landscape.
    Mary S; Fehrentz JA; Damian M; Verdié P; Martinez J; Marie J; Banères JL
    Biochem Soc Trans; 2013 Feb; 41(1):144-7. PubMed ID: 23356274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging opportunities for allosteric modulation of G-protein coupled receptors.
    Wang CI; Lewis RJ
    Biochem Pharmacol; 2013 Jan; 85(2):153-62. PubMed ID: 22975406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational Basis of G Protein-Coupled Receptor Signaling Versatility.
    Wingler LM; Lefkowitz RJ
    Trends Cell Biol; 2020 Sep; 30(9):736-747. PubMed ID: 32622699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent developments in biased agonism.
    Wisler JW; Xiao K; Thomsen AR; Lefkowitz RJ
    Curr Opin Cell Biol; 2014 Apr; 27():18-24. PubMed ID: 24680426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A conformation-equilibrium model captures ligand-ligand interactions and ligand-biased signalling by G-protein coupled receptors.
    Roth S; Bruggeman FJ
    FEBS J; 2014 Oct; 281(20):4659-71. PubMed ID: 25145284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of GPCR conformations by ligands, G-proteins, and arrestins.
    Prossnitz ER; Sklar LA
    Ernst Schering Found Symp Proc; 2006; (2):211-28. PubMed ID: 17703584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational Modification of the Biological Profile of GPCR Ligands through Combination with Other Biologically Active Moieties.
    Huang G; Nimczick M; Decker M
    Arch Pharm (Weinheim); 2015 Aug; 348(8):531-40. PubMed ID: 25941009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterodimerization of g protein-coupled receptors: specificity and functional significance.
    Prinster SC; Hague C; Hall RA
    Pharmacol Rev; 2005 Sep; 57(3):289-98. PubMed ID: 16109836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-invasive optical biosensor for assaying endogenous G protein-coupled receptors in adherent cells.
    Fang Y; Li G; Ferrie AM
    J Pharmacol Toxicol Methods; 2007; 55(3):314-22. PubMed ID: 17207642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational design of dualsteric GPCR ligands: quests and promise.
    Mohr K; Tränkle C; Kostenis E; Barocelli E; De Amici M; Holzgrabe U
    Br J Pharmacol; 2010 Mar; 159(5):997-1008. PubMed ID: 20136835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamics and flexibility of G-protein-coupled receptor conformations and their relevance to drug design.
    Vaidehi N
    Drug Discov Today; 2010 Nov; 15(21-22):951-7. PubMed ID: 20831898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inverse agonists: tools to reveal ligand-specific conformations of G protein-coupled receptors.
    Prather PL
    Sci STKE; 2004 Jan; 2004(215):pe1. PubMed ID: 14722344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.